Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Kaida

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Respiratory Medicine|May 8, 2012
Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven casesYutaro Nakamura, Takafumi Suda, Yusuke Kaida, et al.
Investigational New Drugs|August 18, 2020
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutationsYoichiro Aoshima, Masato Karayama, Naoki Inui, et al.
Investigational New Drugs|February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinomaNorimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Medical Oncology (Northwood, London, England)|June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II studyKoji Nishimoto, Masato Karayama, Naoki Inui, et al.
Respiratory Medicine and Research|October 30, 2025
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trialFumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 6, 2019
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPDYuzo Suzuki, Naoki Inui, Masato Karayama, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancerYusuke Inoue, Naoki Inui, Masato Karayama, et al.
Respirology (Carlton, Vic.)|November 12, 2020
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trialTomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, et al.
Respiration; International Review of Thoracic Diseases|January 5, 2021
Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk FactorsMasato Kono, Yutaro Nakamura, Yasunori Enomoto, et al.
Clinical Lung Cancer|November 3, 2025
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic TherapySuguru Kojima, Yusuke Inoue, Masato Karayama, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Respiratory Medicine|May 8, 2012
Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven casesYutaro Nakamura, Takafumi Suda, Yusuke Kaida, et al.
Investigational New Drugs|August 18, 2020
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutationsYoichiro Aoshima, Masato Karayama, Naoki Inui, et al.
Investigational New Drugs|February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinomaNorimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Medical Oncology (Northwood, London, England)|June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II studyKoji Nishimoto, Masato Karayama, Naoki Inui, et al.
Respiratory Medicine and Research|October 30, 2025
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trialFumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 6, 2019
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPDYuzo Suzuki, Naoki Inui, Masato Karayama, et al.
Journal of Cancer Research and Clinical Oncology|July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancerYusuke Inoue, Naoki Inui, Masato Karayama, et al.
Respirology (Carlton, Vic.)|November 12, 2020
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trialTomoyuki Fujisawa, Hironao Hozumi, Yosuke Kamiya, et al.
Respiration; International Review of Thoracic Diseases|January 5, 2021
Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk FactorsMasato Kono, Yutaro Nakamura, Yasunori Enomoto, et al.
Clinical Lung Cancer|November 3, 2025
Biological Aging and Survival Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Receiving Systemic TherapySuguru Kojima, Yusuke Inoue, Masato Karayama, et al.
Pageof 9